Allergen products development for immunotherapy and allergy diagnosis in moderate to low-sized study populations - Scientific guideline

HumanScientific adviceScientific guidelines

French is available via eTranslation, the European Commission's machine translation service.

Translate to French | Important information about machine translation

This document provides guidance on the clinical development  for allergen products for immunotherapy and allergy diagnosis in moderate to low-sized study populations.

Keywords: Allergen, allergy, allergen immunotherapy, immune therapy, small population

Current version

Guideline on allergen products development for immunotherapy and allergy diagnosis in moderate to lowsized study populations

Adopted Reference Number: EMA/161669/2025 Legal effective date:

English (EN) (389.63 Ko - PDF)

Première publication:
Voir

Overview of comments received on "Guideline on allergen products development for immunotherapy and allergy diagnosis in moderate to low-sized study populations"

Reference Number: (EMA/CHMP/72790/2024)

English (EN) (165.69 Ko - PDF)

Première publication:
Voir

Document history

Draft guideline on allergen products development for immunotherapy and allergy diagnosis in moderate to low-sized study populations

Draft: consultation closed Consultation dates: to Reference Number: EMA/CHMP/72790/2024

English (EN) (408.45 Ko - PDF)

Première publication:
Voir

Share this page